The Joint Statistics
Total Valuation
The Joint has a market cap or net worth of $129.05 million. The enterprise value is $107.03 million.
| Market Cap | 129.05M |
| Enterprise Value | 107.03M |
Important Dates
The next estimated earnings date is Thursday, May 7, 2026, after market close.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
The Joint has 14.32 million shares outstanding. The number of shares has increased by 0.26% in one year.
| Current Share Class | 14.32M |
| Shares Outstanding | 14.32M |
| Shares Change (YoY) | +0.26% |
| Shares Change (QoQ) | -5.31% |
| Owned by Insiders (%) | 15.88% |
| Owned by Institutions (%) | 42.24% |
| Float | 7.22M |
Valuation Ratios
The trailing PE ratio is 47.65 and the forward PE ratio is 28.60.
| PE Ratio | 47.65 |
| Forward PE | 28.60 |
| PS Ratio | 2.34 |
| Forward PS | 2.09 |
| PB Ratio | 8.44 |
| P/TBV Ratio | 8.54 |
| P/FCF Ratio | 384.25 |
| P/OCF Ratio | 69.96 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 144.89, with an EV/FCF ratio of 319.74.
| EV / Earnings | 36.81 |
| EV / Sales | 1.95 |
| EV / EBITDA | 144.89 |
| EV / EBIT | n/a |
| EV / FCF | 319.74 |
Financial Position
The company has a current ratio of 1.59, with a Debt / Equity ratio of 0.13.
| Current Ratio | 1.59 |
| Quick Ratio | 0.81 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | 1.84 |
| Debt / FCF | 6.00 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -1.50% and return on invested capital (ROIC) is -2.94%.
| Return on Equity (ROE) | -1.50% |
| Return on Assets (ROA) | -0.79% |
| Return on Invested Capital (ROIC) | -2.94% |
| Return on Capital Employed (ROCE) | -3.22% |
| Weighted Average Cost of Capital (WACC) | 10.83% |
| Revenue Per Employee | $166,350 |
| Profits Per Employee | $8,810 |
| Employee Count | 330 |
| Asset Turnover | 0.76 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, The Joint has paid $38,653 in taxes.
| Income Tax | 38,653 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -13.65% in the last 52 weeks. The beta is 1.23, so The Joint's price volatility has been higher than the market average.
| Beta (5Y) | 1.23 |
| 52-Week Price Change | -13.65% |
| 50-Day Moving Average | 8.83 |
| 200-Day Moving Average | 9.47 |
| Relative Strength Index (RSI) | 57.21 |
| Average Volume (20 Days) | 70,717 |
Short Selling Information
The latest short interest is 884,684, so 6.18% of the outstanding shares have been sold short.
| Short Interest | 884,684 |
| Short Previous Month | 987,667 |
| Short % of Shares Out | 6.18% |
| Short % of Float | 12.25% |
| Short Ratio (days to cover) | 15.46 |
Income Statement
In the last 12 months, The Joint had revenue of $54.90 million and earned $2.91 million in profits. Earnings per share was $0.19.
| Revenue | 54.90M |
| Gross Profit | 43.67M |
| Operating Income | -905,478 |
| Pretax Income | -229,504 |
| Net Income | 2.91M |
| EBITDA | 738,683 |
| EBIT | -905,478 |
| Earnings Per Share (EPS) | $0.19 |
Balance Sheet
The company has $23.60 million in cash and $2.01 million in debt, with a net cash position of $21.59 million or $1.51 per share.
| Cash & Cash Equivalents | 23.60M |
| Total Debt | 2.01M |
| Net Cash | 21.59M |
| Net Cash Per Share | $1.51 |
| Equity (Book Value) | 15.08M |
| Book Value Per Share | 1.06 |
| Working Capital | 19.27M |
Cash Flow
In the last 12 months, operating cash flow was $1.84 million and capital expenditures -$1.50 million, giving a free cash flow of $334,724.
| Operating Cash Flow | 1.84M |
| Capital Expenditures | -1.50M |
| Depreciation & Amortization | 1.64M |
| Net Borrowing | -4,354 |
| Free Cash Flow | 334,724 |
| FCF Per Share | $0.02 |
Margins
Gross margin is 79.55%, with operating and profit margins of -1.65% and 5.30%.
| Gross Margin | 79.55% |
| Operating Margin | -1.65% |
| Pretax Margin | -0.42% |
| Profit Margin | 5.30% |
| EBITDA Margin | 1.35% |
| EBIT Margin | -1.65% |
| FCF Margin | 0.61% |
Dividends & Yields
The Joint does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.26% |
| Shareholder Yield | -0.26% |
| Earnings Yield | 2.26% |
| FCF Yield | 0.26% |
Analyst Forecast
The average price target for The Joint is $17.00, which is 88.68% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $17.00 |
| Price Target Difference | 88.68% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
The Joint has an Altman Z-Score of 2.71 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.71 |
| Piotroski F-Score | 5 |